5l5i
From Proteopedia
(Difference between revisions)
(2 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
- | + | ||
==Yeast 20S proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 9== | ==Yeast 20S proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 9== | ||
- | <StructureSection load='5l5i' size='340' side='right' caption='[[5l5i]], [[Resolution|resolution]] 2.90Å' scene=''> | + | <StructureSection load='5l5i' size='340' side='right'caption='[[5l5i]], [[Resolution|resolution]] 2.90Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[5l5i]] is a | + | <table><tr><td colspan='2'>[[5l5i]] is a 20 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [https://en.wikipedia.org/wiki/Saccharomyces_cerevisiae_S288C Saccharomyces cerevisiae S288C]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5L5I OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5L5I FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=38X:N-[(3-METHYL-1H-INDEN-2-YL)CARBONYL]-D-ALANYL-N-[(2S,4R)-1-CYCLOHEXYL-5-HYDROXY-4-METHYL-3-OXOPENTAN-2-YL]-L-TRYPTOPHANAMIDE'>38X</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=MES:2-(N-MORPHOLINO)-ETHANESULFONIC+ACID'>MES</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.9Å</td></tr> |
- | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=38X:N-[(3-METHYL-1H-INDEN-2-YL)CARBONYL]-D-ALANYL-N-[(2S,4R)-1-CYCLOHEXYL-5-HYDROXY-4-METHYL-3-OXOPENTAN-2-YL]-L-TRYPTOPHANAMIDE'>38X</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=MES:2-(N-MORPHOLINO)-ETHANESULFONIC+ACID'>MES</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene></td></tr> | |
- | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5l5i FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5l5i OCA], [https://pdbe.org/5l5i PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5l5i RCSB], [https://www.ebi.ac.uk/pdbsum/5l5i PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5l5i ProSAT]</span></td></tr> | |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
</table> | </table> | ||
- | {{Large structure}} | ||
- | == Disease == | ||
- | [[http://www.uniprot.org/uniprot/PSB8_HUMAN PSB8_HUMAN]] CANDLE syndrome;Nakajo-Nishimura syndrome;JMP syndrome. The disease is caused by mutations affecting the gene represented in this entry. | ||
== Function == | == Function == | ||
- | [ | + | [https://www.uniprot.org/uniprot/PSA2_YEAST PSA2_YEAST] The proteasome degrades poly-ubiquitinated proteins in the cytoplasm and in the nucleus. It is essential for the regulated turnover of proteins and for the removal of misfolded proteins. The proteasome is a multicatalytic proteinase complex that is characterized by its ability to cleave peptides with Arg, Phe, Tyr, Leu, and Glu adjacent to the leaving group at neutral or slightly basic pH. It has an ATP-dependent proteolytic activity. |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 23: | Line 19: | ||
</div> | </div> | ||
<div class="pdbe-citations 5l5i" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 5l5i" style="background-color:#fffaf0;"></div> | ||
+ | |||
+ | ==See Also== | ||
+ | *[[Proteasome 3D structures|Proteasome 3D structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: | + | [[Category: Homo sapiens]] |
- | [[Category: | + | [[Category: Large Structures]] |
- | [[Category: | + | [[Category: Saccharomyces cerevisiae S288C]] |
- | [[Category: | + | [[Category: Groll M]] |
- | [[Category: | + | [[Category: Huber EM]] |
- | + | ||
- | + | ||
- | + |
Current revision
Yeast 20S proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 9
|